Influence of new 6-benzylaminopurine derivatives on micropropagation of selected broad-leaved forest tree species
Public support
Provider
Czech Science Foundation
Programme
Standard projects
Call for proposals
Standardní projekty 10 (SGA02007GA-ST)
Main participants
—
Contest type
VS - Public tender
Contract ID
206/07/0570
Alternative language
Project name in Czech
Vliv nových derivátů 6-benzylaminopurinu na mikropropagaci vybraných druhů lesních dřevin
Annotation in Czech
Navrhovaný projekt je zaměřen na studium vlivu nově objevených vysoce biologicky aktivních derivátů 6-benzylaminopurinu na mikropropagaci u vybraných druhů lesních dřevin. V souvislosti s předpokládaným výrazným vlivem testovaných cytokininů na multiplikaci, rhizogenezi a rannou senescenci explantátů in-vitro budou také měřeny endogenní hladiny cytokininů a dalších skupin rostlinných hormonů a biologicky aktivních látek s předpokládaným vlivem na tyto procesy.
Scientific branches
R&D category
ZV - Basic research
CEP classification - main branch
EF - Botany
CEP - secondary branch
ED - Physiology
CEP - another secondary branch
EI - Biotechnology and bionics
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
10611 - Plant sciences, botany<br>10612 - Mycology<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30105 - Physiology (including cytology)<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
.
Solution timeline
Realization period - beginning
Jan 1, 2007
Realization period - end
Dec 31, 2009
Project status
U - Finished project
Latest support payment
Apr 22, 2009
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP10-GA0-GA-U/02:2
Data delivery date
Jan 22, 2015
Finance
Total approved costs
2,455 thou. CZK
Public financial support
2,455 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
0 thou. CZK